The global contrast media injectors market size is expected to register a significant CAGR of over 6% during the forecast period 2022 to 2028. The increasing prevalence of chronic diseases such as cardiovascular and cancer diseases and the rising demand for minimally invasive surgeries are some major factors to drive the market growth. Furthermore, technological advancement, fast approval by the government for contrast agents, and increasing investment are further anticipated to fuel the market growth over the forecast period. Moreover, the increasing use of CT (Computed Tomography) systems in some previous years is expected to increase the demand for CT injectors during the forecast period.
Market Drivers:
Increasing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases, such as cardiovascular disorders, cancer, and neurological conditions, drives the demand for medical imaging procedures that require contrast media injectors. These injectors are used to deliver contrast agents during imaging exams, enhancing the visualization of blood vessels, organs, and tissues for accurate diagnosis and treatment planning.
Growing Aging Population: The global aging population is a significant driver for the contrast media injectors market. With the aging population, the incidence of age-related diseases and conditions increases, leading to a higher demand for medical imaging procedures. Contrast media injectors play a crucial role in these procedures, contributing to market growth.
Technological Advancements in Imaging Techniques: Technological advancements in medical imaging techniques, such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography, have increased the demand for contrast media injectors. Advanced imaging modalities require precise and automated injection of contrast agents to achieve optimal image quality, leading to the adoption of contrast media injectors.
Increasing Diagnostic Imaging Procedures: The growing number of diagnostic imaging procedures, both in hospitals and diagnostic imaging centers, contributes to the demand for contrast media injectors. These injectors enable efficient and accurate delivery of contrast agents during various imaging exams, including CT scans, MRI scans, and angiograms, improving the diagnostic capabilities of these procedures.
Rising Awareness and Focus on Early Disease Detection: There is an increasing emphasis on early disease detection and prevention, driving the demand for diagnostic imaging procedures that utilize contrast media injectors. Contrast-enhanced imaging techniques help in the early detection of diseases, facilitating prompt intervention and improving patient outcomes.
Advancements in Contrast Media Injector Technology: The development of advanced contrast media injector technologies, such as dual-head injectors, syringeless injectors, and automated injectors, has improved the efficiency, safety, and ease of use in contrast agent administration. These advancements contribute to the market growth by enhancing the capabilities and user experience of contrast media injectors.
Increasing Healthcare Expenditure: The overall increase in healthcare expenditure, driven by factors such as population growth, rising disease burden, and improving healthcare infrastructure, positively impacts the contrast media injectors market. Healthcare facilities allocate resources to invest in advanced medical imaging technologies, including contrast media injectors, to meet the growing demand for imaging procedures.
Regulatory Guidelines and Standards: The existence of regulatory guidelines and standards for contrast media administration and patient safety influences the market for contrast media injectors. Compliance with these regulations and standards is essential for healthcare facilities to ensure patient safety and maintain quality standards, driving the adoption of contrast media injectors.
Strategic Collaborations and Partnerships: Collaborations and partnerships between manufacturers of contrast media injectors and imaging equipment companies contribute to market growth. These collaborations aim to develop integrated solutions, optimize workflow, and enhance compatibility between contrast media injectors and imaging systems, creating value for end-users.
Market Snapshot:
| Benchmark Year | 2022 | ||
| Market Size | lock | ||
| Market Growth (CAGR) | > 6% (2023-2030) | ||
| Largest Market Share | North America | ||
| Analysis Period | 2020-2030 | ||
| Market Players | Bayer HealthCare LLC, GE Healthcare, Bracco Group, Ulrich Medical, and Guerbet Group |
Market Insights:
The global contrast media injectors market is bifurcated into product, type, application, end-use, and geography. On the basis of application, the market is further segmented into radiology, interventional cardiology, and interventional radiology. The radiology segment dominated the market in 2021 and expected to hold the largest revenue share of around half of the market by the end of the analysis period. The increasing demand for noninvasive imaging technologies such as MRI and CT scans is a major factor to drive the segment growth. On the flip side, the increasing prevalence of cardiac conditions is expected to grow the interventional cardiology segment at the fastest growth rate over the forecast period.
On the basis of end-use, the market is segmented into hospitals, diagnostics centers, and ambulatory surgery centers. The hospitals segment dominated the global contrast media injectors market in 2021 and expected to hold the largest revenue share of over two-thirds market share by the end of the analysis period. The rising prevalence of cardiovascular disease, cancer, and neurological disorders is a primary factor driving the segment growth. The increasing demand for contrast media injectors in various applications such as interventional radiology, interventional cardiology, and radiology is further expected to fuel the segment growth. Moreover, the increasing investment in healthcare infrastructure in developing economies is projected to fuel the segment growth over the forecast period.
To know more about the report, request sample papers
The contrast media injectors comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2022 to 2028. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market, and expert opinions obtained from interviews with industry executives and experts from prominent companies.
The contrast media injectors market research report presents the analysis of each segment from 2019 to 2028 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.
Historical & Forecast Period
- 2019-20 – Historical Year
- 2021 – Base Year
- 2022-2028 – Forecast Period
Market Segmentation:
By Product:
- Injector Systems
- CT Injector Systems
- MRI Injector Systems
- Cardiovascular/Angiography Injector Systems
- Consumables
- Tubing
- Syringe
- Others
By Type:
- Single Head Injectors
- Dual-Head Injectors
- Syringe less Injectors
By Application:
- Radiology
- Interventional Cardiology
- Interventional Radiology
By End-Use:
- Hospitals
- Diagnostics Centers
- Ambulatory Surgery Centers
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Regional Analysis:
Geographically, North America dominated the global contrast media injectors market in 2021 and accounted to hold the largest market share of over one-third share by the end of the analysis period. The increasing number of cardiovascular and cancer patients and the increasing demand for minimally invasive surgeries are some of the major factors to drive the market growth in the region. Furthermore, technological advancement, availability of well-structured healthcare infrastructure, and the growing demand for advanced diagnostic procedures are further anticipated to drive market growth over the forecast period. On the flip side, the increasing demand for the product in developing economies is expected to register the fastest growth rate of the market in the Asia Pacific region.
Competitive Assessment:
Some of the leading market players operating in the global contrast media injectors market are Bayer HealthCare LLC, GE Healthcare, Bracco Group, Ulrich Medical, and Guerbet Group. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.
Key Companies:
- Bayer HealthCare LLC
- GE Healthcare
- Bracco Group
- Ulrich Medical
- Guerbet Group
- Medtron AG
- Nemoto Kyorindo Co., Ltd.
- Hong Kong Medi Co Limited
- Hilin Life Products
- Sino Medical-Device Technology Co. Ltd.
Key Questions Answered by Contrast Media Injectors Market Report
- Global contrast media injectors market forecasts from 2022-2028
- Regional market forecasts from 2022-2028 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
- Country-level forecasts from 2022-2028 covering 15 major countries from the regions as mentioned above
- Contrast media injectors submarket forecasts from 2022-2028 covering the market by product, by type, by application, by end-use, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis about the market
- Analysis of the key factors driving and restraining the growth of the global, regional, and country-level contrast media injectors markets from 2022-2028
- Competitive Landscape and market positioning of top 10 players operating in the market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Contrast Media Injectors Market Portraiture
2.2. Global Contrast Media Injectors Market, by Product, 2021 (USD Mn)
2.3. Global Contrast Media Injectors Market, by Type, 2021 (USD Mn)
2.4. Global Contrast Media Injectors Market, by Application, 2021 (USD Mn)
2.5. Global Contrast Media Injectors Market, by End-Use, 2021 (USD Mn)
2.6. Global Contrast Media Injectors Market, by Geography, 2021 (USD Mn)
3. Global Contrast Media Injectors Market Analysis
3.1. Contrast Media Injectors Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis
4. Global Contrast Media Injectors Market By Product, 2019 – 2028 (USD Mn)
4.1. Overview
4.2. Injector Systems
4.2.1. CT Injector Systems
4.2.2. MRI Injector Systems
4.2.3. Cardiovascular/Angiography Injector Systems
4.3. Consumables
4.3.1. Tubing
4.3.2. Syringe
4.3.3. Others
5. Global Contrast Media Injectors Market By Type, 2019 – 2028 (USD Mn)
5.1. Overview
5.2. Single Head Injectors
5.3. Dual-Head Injectors
5.4. Syringe less Injectors
6. Global Contrast Media Injectors Market By Application, 2019 – 2028 (USD Mn)
6.1. Overview
6.2. Radiology
6.3. Interventional Cardiology
6.4. Interventional Radiology
7. Global Contrast Media Injectors Market By End-Use, 2019 – 2028 (USD Mn)
7.1. Overview
7.2. Hospitals
7.3. Diagnostics Centers
7.4. Ambulatory Surgery Centers
8. North America Contrast Media Injectors Market Analysis and Forecast, 2019 – 2028 (USD Mn)
8.1. Overview
8.2. North America Contrast Media Injectors Market by Product (2019-2028 USD Mn)
8.3. North America Contrast Media Injectors Market by Type (2019-2028 USD Mn)
8.4. North America Contrast Media Injectors Market by Application (2019-2028 USD Mn)
8.5. North America Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
8.6. North America Contrast Media Injectors Market by Country (2019-2028 USD Mn)
8.6.1. U.S.
8.6.1.1. U.S. Contrast Media Injectors Market by Product (2019-2028 USD Mn)
8.6.1.2. U.S. Contrast Media Injectors Market by Type (2019-2028 USD Mn)
8.6.1.3. U.S. Contrast Media Injectors Market by Application (2019-2028 USD Mn)
8.6.1.4. U.S. Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
8.6.2. Canada
8.6.2.1. Canada Contrast Media Injectors Market by Product (2019-2028 USD Mn)
8.6.2.2. Canada Contrast Media Injectors Market by Type (2019-2028 USD Mn)
8.6.2.3. Canada Contrast Media Injectors Market by Application (2019-2028 USD Mn)
8.6.2.4. Canada Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
9. Europe Contrast Media Injectors Market Analysis and Forecast, 2019 – 2028 (USD Mn)
9.1. Overview
9.2. Europe Contrast Media Injectors Market by Product (2019-2028 USD Mn)
9.3. Europe Contrast Media Injectors Market by Type (2019-2028 USD Mn)
9.4. Europe Contrast Media Injectors Market by Application (2019-2028 USD Mn)
9.5. Europe Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
9.6. Europe Contrast Media Injectors Market by Country (2019-2028 USD Mn)
9.6.1. Germany
9.6.1.1. Germany Contrast Media Injectors Market by Product (2019-2028 USD Mn)
9.6.1.2. Germany Contrast Media Injectors Market by Type (2019-2028 USD Mn)
9.6.1.3. Germany Contrast Media Injectors Market by Application (2019-2028 USD Mn)
9.6.1.4. Germany Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
9.6.2. U.K.
9.6.2.1. U.K. Contrast Media Injectors Market by Product (2019-2028 USD Mn)
9.6.2.2. U.K. Contrast Media Injectors Market by Type (2019-2028 USD Mn)
9.6.2.3. U.K. Contrast Media Injectors Market by Application (2019-2028 USD Mn)
9.6.2.4. U.K. Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
9.6.3. France
9.6.3.1. France Contrast Media Injectors Market by Product (2019-2028 USD Mn)
9.6.3.2. France Contrast Media Injectors Market by Type (2019-2028 USD Mn)
9.6.3.3. France Contrast Media Injectors Market by Application (2019-2028 USD Mn)
9.6.3.4. France Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
9.6.4. Italy
9.6.4.1. Italy Contrast Media Injectors Market by Product (2019-2028 USD Mn)
9.6.4.2. Italy Contrast Media Injectors Market by Type (2019-2028 USD Mn)
9.6.4.3. Italy Contrast Media Injectors Market by Application (2019-2028 USD Mn)
9.6.4.4. Italy Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
9.6.5. Rest of Europe
9.6.5.1. Rest of Europe Contrast Media Injectors Market by Type (2019-2028 USD Mn)
9.6.5.2. Rest of Europe Contrast Media Injectors Market by Product (2019-2028 USD Mn)
9.6.5.3. Rest of Europe Contrast Media Injectors Market by Application (2019-2028 USD Mn)
9.6.5.4. Rest of Europe Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
10. Asia Pacific Contrast Media Injectors Market Analysis and Forecast, 2019 – 2028 (USD Mn)
10.1. Overview
10.2. Asia Pacific Contrast Media Injectors Market by Product (2019-2028 USD Mn)
10.3. Asia Pacific Contrast Media Injectors Market by Type (2019-2028 USD Mn)
10.4. Asia Pacific Contrast Media Injectors Market by Application (2019-2028 USD Mn)
10.5. Asia Pacific Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
10.6. Asia Pacific Contrast Media Injectors Market by Country (2019-2028 USD Mn)
10.6.1. China
10.6.1.1. China Contrast Media Injectors Market by Product (2019-2028 USD Mn)
10.6.1.2. China Contrast Media Injectors Market by Type (2019-2028 USD Mn)
10.6.1.3. China Contrast Media Injectors Market by Application (2019-2028 USD Mn)
10.6.1.4. China Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
10.6.2. Japan
10.6.2.1. Japan Contrast Media Injectors Market by Product (2019-2028 USD Mn)
10.6.2.2. Japan Contrast Media Injectors Market by Type (2019-2028 USD Mn)
10.6.2.3. Japan Contrast Media Injectors Market by Application (2019-2028 USD Mn)
10.6.2.4. Japan Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
10.6.3. India
10.6.3.1. India Contrast Media Injectors Market by Product (2019-2028 USD Mn)
10.6.3.2. India Contrast Media Injectors Market by Type (2019-2028 USD Mn)
10.6.3.3. India Contrast Media Injectors Market by Application (2019-2028 USD Mn)
10.6.3.4. India Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
10.6.4. Rest of Asia Pacific
10.6.4.1. Rest of Asia Pacific Contrast Media Injectors Market by Product (2019-2028 USD Mn)
10.6.4.2. Rest of Asia Pacific Contrast Media Injectors Market by Type (2019-2028 USD Mn)
10.6.4.3. Rest of Asia Pacific Contrast Media Injectors Market by Application (2019-2028 USD Mn)
10.6.4.4. Rest of Asia Pacific Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
11. Latin America (LATAM) Contrast Media Injectors Market Analysis and Forecast, 2019 – 2028 (USD Mn)
11.1. Overview
11.2. Latin America Contrast Media Injectors Market by Product (2019-2028 USD Mn)
11.3. Latin America Contrast Media Injectors Market by Type (2019-2028 USD Mn)
11.4. Latin America Contrast Media Injectors Market by Application (2019-2028 USD Mn)
11.5. Latin America Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
11.6. Latin America Contrast Media Injectors Market by Country (2019-2028 USD Mn)
11.6.1. Brazil
11.6.1.1. Brazil Contrast Media Injectors Market by Product (2019-2028 USD Mn)
11.6.1.2. Brazil Contrast Media Injectors Market by Type (2019-2028 USD Mn)
11.6.1.3. Brazil Contrast Media Injectors Market by Application (2019-2028 USD Mn)
11.6.1.4. Brazil Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
11.6.2. Mexico
11.6.2.1. Mexico Contrast Media Injectors Market by Product (2019-2028 USD Mn)
11.6.2.2. Mexico Contrast Media Injectors Market by Type (2019-2028 USD Mn)
11.6.2.3. Mexico Contrast Media Injectors Market by Application (2019-2028 USD Mn)
11.6.2.4. Mexico Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
11.6.3. Rest of Latin America
11.6.3.1. Rest of Latin America Contrast Media Injectors Market by Product (2019-2028 USD Mn)
11.6.3.2. Rest of Latin America Contrast Media Injectors Market by Type (2019-2028 USD Mn)
11.6.3.3. Rest of Latin America Contrast Media Injectors Market by Application (2019-2028 USD Mn)
11.6.3.4. Rest of Latin America Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
12. Middle East and Africa Contrast Media Injectors Market Analysis and Forecast, 2019 – 2028 (USD Mn)
12.1. Overview
12.2. MEA Contrast Media Injectors Market by Product (2019-2028 USD Mn)
12.3. MEA Contrast Media Injectors Market by Type (2019-2028 USD Mn)
12.4. MEA Contrast Media Injectors Market by Application (2019-2028 USD Mn)
12.5. MEA Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
12.6. Middle East and Africa Contrast Media Injectors Market, by Country (2019-2028 USD Mn)
12.6.1. GCC
12.6.1.1. GCC Contrast Media Injectors Market by Product (2019-2028 USD Mn)
12.6.1.2. GCC Contrast Media Injectors Market by Type (2019-2028 USD Mn)
12.6.1.3. GCC Contrast Media Injectors Market by Application (2019-2028 USD Mn)
12.6.1.4. GCC Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
12.6.2. South Africa
12.6.2.1. South Africa Contrast Media Injectors Market by Product (2019-2028 USD Mn)
12.6.2.2. South Africa Contrast Media Injectors Market by Type (2019-2028 USD Mn)
12.6.2.3. South Africa Contrast Media Injectors Market by Application (2019-2028 USD Mn)
12.6.2.4. South Africa Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Contrast Media Injectors Market by Product (2019-2028 USD Mn)
12.6.3.2. Rest of MEA Contrast Media Injectors Market by Type (2019-2028 USD Mn)
12.6.3.3. Rest of MEA Contrast Media Injectors Market by Application (2019-2028 USD Mn)
12.6.3.4. Rest of MEA Contrast Media Injectors Market by End-User (2019-2028 USD Mn)
13. Company Profiles
13.1. Bayer HealthCare LLC
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. GE Healthcare
13.2.1. Business Description
13.2.2. Financial Health and Budget Allocation
13.2.3. Product Positions/Portfolio
13.2.4. Recent Development
13.2.5. SWOT Analysis
13.3. Bracco Group
13.3.1. Business Description
13.3.2. Financial Health and Budget Allocation
13.3.3. Product Positions/Portfolio
13.3.4. Recent Development
13.3.5. SWOT Analysis
13.4. Ulrich Medical
13.4.1. Business Description
13.4.2. Financial Health and Budget Allocation
13.4.3. Product Positions/Portfolio
13.4.4. Recent Development
13.4.5. SWOT Analysis
13.5. Guerbet Group
13.5.1. Business Description
13.5.2. Financial Health and Budget Allocation
13.5.3. Product Positions/Portfolio
13.5.4. Recent Development
13.5.5. SWOT Analysis
13.6. Medtron AG
13.6.1. Business Description
13.6.2. Financial Health and Budget Allocation
13.6.3. Product Positions/Portfolio
13.6.4. Recent Development
13.6.5. SWOT Analysis
13.7. Nemoto Kyorindo Co., Ltd.
13.7.1. Business Description
13.7.2. Financial Health and Budget Allocation
13.7.3. Product Positions/Portfolio
13.7.4. Recent Development
13.7.5. SWOT Analysis
13.8. Hong Kong Medi Co Limited
13.8.1. Business Description
13.8.2. Financial Health and Budget Allocation
13.8.3. Product Positions/Portfolio
13.8.4. Recent Development
13.8.5. SWOT Analysis
13.9. Hilin Life Products
13.9.1. Business Description
13.9.2. Financial Health and Budget Allocation
13.9.3. Product Positions/Portfolio
13.9.4. Recent Development
13.9.5. SWOT Analysis
13.10. Sino Medical-Device Technology Co. Ltd.
13.10.1. Business Description
13.10.2. Financial Health and Budget Allocation
13.10.3. Product Positions/Portfolio
13.10.4. Recent Development
13.10.5. SWOT Analysis
$ 5200/- Multi User License
We understand that every business has unique requirements. This report can be customized based on:
- Deep regional & country-level market intelligence
- Application-specific and end-use industry segmentation
- Competitive landscape & strategic benchmarking
- Go-to-market and expansion strategy insights
- Custom data cuts aligned to your business goals
- Structured Primary Research Framework
- On-Demand Industry Expert Interviews Available
- Dedicated Analyst Support
- Custom Data On Request
- Post-Purchase Strategy Consultation
- Complimentary 30-min Analyst Session
- 30% of Our Clients Are Returning Enterprise Buyers
Our Clients
